Wednesday, December 7, 2016

British Journal of Cancer - Table of Contents alert Volume 115 Issue 12

If you are unable to see the message below, click here to view.
British Journal of Cancer


Volume 115, Issue 12 (1441-1583)
Published online 6 December 2016

In this issue
Clinical Studies
Translational Therapeutics
Molecular Diagnostics

Also new today
Advance online publication
Digital Edition
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Blood Cancer Journal is an online-only, open access journal, publishing high quality research on hematologic malignancies and related disorders.

Explore the benefits of submitting your next research article.



Trastuzumab cardiotoxiciy: the age-old balance of risk and benefit

Michael S Ewer and Steven M Ewer

Br J Cancer 2016 115: 1441-1442; advance online publication, November 22, 2016; 10.1038/bjc.2016.381

Full Text



A new roadmap to improve translation of imaging biomarkers

Michael Skwarski and Geoff S Higgins

Br J Cancer 2016 115: 1443-1444; advance online publication, November 15, 2016; 10.1038/bjc.2016.374

Full Text



Cell of origin of glioma: biological and clinical implications

Sheila R Alcantara Llaguno and Luis F Parada

Br J Cancer 2016 115: 1445-1450; advance online publication, November 10, 2016; 10.1038/bjc.2016.354

Abstract | Full Text

The cell-autonomous mechanisms underlying the activity of metformin as an anticancer drug

Francesca Sacco, Alberto Calderone, Luisa Castagnoli and Gianni Cesareni

Br J Cancer 2016 115: 1451-1456; advance online publication, November 22, 2016; 10.1038/bjc.2016.385

Abstract | Full Text

Clinical Studies


Acute interstitial nephritis related to immune checkpoint inhibitors

Julie Belliere, Nicolas Meyer, Julien Mazieres, Sylvie Ollier, Serge Boulinguez, Audrey Delas, David Ribes and Stanislas Faguer

Br J Cancer 2016 115: 1457-1461; advance online publication, November 10, 2016; 10.1038/bjc.2016.358

Abstract | Full Text

Trastuzumab-associated cardiac events in the Persephone trial

Helena M Earl, Anne-Laure Vallier, Janet Dunn, Shrushma Loi, Emma Ogburn, Karen McAdam, Luke Hughes-Davies, Adrian Harnett, Jean Abraham, Andrew Wardley, David A Cameron, David Miles, Ioannis Gounaris, Chris Plummer and Louise Hiller

Br J Cancer 2016 115: 1462-1470; advance online publication, November 22, 2016; 10.1038/bjc.2016.357

Abstract | Full Text

The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients

Matteo Lambertini, Ana Catarina Pinto, Lieveke Ameye, Lynn Jongen, Lucia Del Mastro, Fabio Puglisi, Francesca Poggio, Marta Bonotto, Giuseppe Floris, Kathleen Van Asten, Hans Wildiers, Patrick Neven, Evandro de Azambuja, Marianne Paesmans and Hatem A Azim Jr

Br J Cancer 2016 115: 1471-1478; advance online publication, November 1, 2016; 10.1038/bjc.2016.359

Abstract | Full Text

A national cluster-randomised controlled trial to examine the effect of enhanced reminders on the socioeconomic gradient in uptake in bowel cancer screening

Rosalind Raine, Sue M Moss, Christian von Wagner, Wendy Atkin, Ines Kralj Hans, Rosemary Howe, Francesca Solmi, Stephen Morris, Nicholas Counsell, Allan Hackshaw, Stephen Halloran, Graham Handley, Richard F Logan, Sandra Rainbow, Steve Smith, Julia Snowball, Helen Seaman, Mary Thomas, Samuel G Smith, Lesley M McGregor, Gemma Vart, Jane Wardle and Stephen W Duffy

Br J Cancer 2016 115: 1479-1486; advance online publication, November 22, 2016; 10.1038/bjc.2016.365

Abstract | Full Text

Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trial

Andrew J Coldman, Lovedeep Gondara, Laurie W Smith, Dirk van Niekerk, Kathy Ceballos, Mel Krajden, Darrel Cook, David J Quinlan, Marette Lee, Gavin CE Stuart, Stuart Peacock, Ruth Elwood Martin, Laura Gentile, Eduardo L Franco and Gina S Ogilvie

Br J Cancer 2016 115: 1487-1494; advance online publication, November 17, 2016; 10.1038/bjc.2016.368

Abstract | Full Text

Determining cancer survivors' preferences to inform new models of follow-up care

Peter Murchie, Patricia F Norwood, Marta Pietrucin-Materek, Terry Porteous, Philip C Hannaford and Mandy Ryan

Br J Cancer 2016 115: 1495-1503; advance online publication, November 1, 2016; 10.1038/bjc.2016.352

Abstract | Full Text

Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment

J L Kuiper, S M S Hashemi, E Thunnissen, P J F Snijders, K Grünberg, E Bloemena, D Sie, P E Postmus, D A M Heideman and E F Smit

Br J Cancer 2016 115: 1504-1512; advance online publication, November 22, 2016; 10.1038/bjc.2016.372

Abstract | Full Text

Translational Therapeutics


An individualised signature for predicting response with concordant survival benefit for lung adenocarcinoma patients receiving platinum-based chemotherapy

Lishuang Qi, Yang Li, Yuan Qin, Gengen Shi, Tianhao Li, Jiasheng Wang, Libin Chen, Yunyan Gu, Wenyuan Zhao and Zheng Guo

Br J Cancer 2016 115: 1513-1519; advance online publication, November 17, 2016; 10.1038/bjc.2016.370

Abstract | Full Text

Impact of SPARC expression on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: a pooled analysis from prospective clinical and translational trials

Steffen Ormanns, Michael Haas, Sibylle Baechmann, Annelore Altendorf-Hofmann, Anna Remold, Detlef Quietzsch, Michael R Clemens, Martin Bentz, Michael Geissler, Helmut Lambertz, Stephan Kruger, Thomas Kirchner, Volker Heinemann and Stefan Boeck

Br J Cancer 2016 115: 1520-1529; advance online publication, November 1, 2016; 10.1038/bjc.2016.355

Abstract | Full Text

Molecular Diagnostics


Aldo-keto reductases are biomarkers of NRF2 activity and are co-ordinately overexpressed in non-small cell lung cancer

A Kenneth MacLeod, Lourdes Acosta-Jimenez, Philip J Coates, Michael McMahon, Frank A Carey, Tadashi Honda, Colin J Henderson and C Roland Wolf

Br J Cancer 2016 115: 1530-1539; advance online publication, November 8, 2016; 10.1038/bjc.2016.363

Abstract | Full Text

Expression of somatostatin receptors 2 and 5 in circulating tumour cells from patients with neuroendocrine tumours

Alexa Childs, Clare Vesely, Leah Ensell, Helen Lowe, Tu Vinh Luong, Martyn E Caplin, Christos Toumpanakis, Christina Thirlwell, John A Hartley and Tim Meyer

Br J Cancer 2016 115: 1540-1547; advance online publication, November 22, 2016; 10.1038/bjc.2016.377

Abstract | Full Text

miR-146a-5p mediates epithelial–mesenchymal transition of oesophageal squamous cell carcinoma via targeting Notch2

Cong Wang, Wenxue Zhang, Lin Zhang, Xuan Chen, Fang Liu, Jing Zhang, Shanghui Guan, Yi Sun, Pengxiang Chen, Ding Wang, Effat Un Nesa, Yufeng Cheng and George M Yousef

Br J Cancer 2016 115: 1548-1554; advance online publication, November 10, 2016; 10.1038/bjc.2016.367

Abstract | Full Text

A protein fragment derived from DNA-topoisomerase I as a novel tumour-associated antigen for the detection of early stage carcinoma

Shang-mian Yie, Shang-rong Ye, Xiao-li Ma, Ke Xie, Jian-bo Zhang, Mei Cao, Xu He, Zhen-bo Hu, Cheng-lu Yang, Jia Zhang and Jie Zeng

Br J Cancer 2016 115: 1555-1564; advance online publication, November 22, 2016; 10.1038/bjc.2016.369

Abstract | Full Text

Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence

Sjoerd H den Uil, Veerle M H Coupé, Janneke F Linnekamp, Evert van den Broek, Jeroen A C M Goos, Pien M Delis-van Diemen, Eric J Th Belt, Nicole C T van Grieken, Patricia M Scott, Louis Vermeulen, Jan Paul Medema, Herman Bril, Hein B A C Stockmann, Robert T Cormier, Gerrit A Meijer and Remond J A Fijneman

Br J Cancer 2016 115: 1565-1574; advance online publication, November 17, 2016; 10.1038/bjc.2016.376

Abstract | Full Text

Precision medicine in cancer: challenges and recommendations from an EU-funded cervical cancer biobanking study

Sanne Samuels, Balazs Balint, Heiko von der Leyen, Philippe Hupé, Leanne de Koning, Choumouss Kamoun, Windy Luscap-Rondof, Ulrike Wittkop, Ksenia Bagrintseva, Marina Popovic, Atttila Kereszt, Els Berns, Gemma G Kenter, Ekaterina S Jordanova, Maud Kamal and Susy Scholl

Br J Cancer 2016 115: 1575-1583; advance online publication, November 22, 2016; 10.1038/bjc.2016.340

Abstract | Full Text

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group

No comments: